XML 95 R62.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurement (Details) - Schedule of provides the changes in the fair value of the convertible notes - Blade Therapeutics, Inc. [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Fair Value Measurement (Details) - Schedule of provides the changes in the fair value of the convertible notes [Line Items]    
Beginning balance $ 23,410
Proceeds from issuance 2021 convertible notes and warrants 20,000  
Proceeds allocated to 2021 common stock warrants and tranche obligation at fair value (1,692)  
Proceeds from issuance 2020 convertible notes and warrants   20,716
Proceeds allocated to 2020 common stock warrants at fair value   (630)
Interest expense accrued 2,145 647
Change in fair value of convertible notes 2,497 2,677
Ending balance $ 46,360 $ 23,410